Your browser doesn't support javascript.
loading
The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients.
Gayarre, Javier; Kamieniak, Marta M; Cazorla-Jiménez, Alicia; Muñoz-Repeto, Ivan; Borrego, Salud; García-Donas, Jesús; Hernando, Susana; Robles-Díaz, Luis; García-Bueno, José M; Ramón Y Cajal, Teresa; Hernández-Agudo, Elena; Heredia Soto, Victoria; Márquez-Rodas, Ivan; Echarri, María José; Lacambra-Calvet, Carmen; Sáez, Raquel; Cusidó, Maite; Redondo, Andrés; Paz-Ares, Luis; Hardisson, David; Mendiola, Marta; Palacios, José; Benítez, Javier; García, María José.
Afiliação
  • Gayarre J; Human Genetics Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Kamieniak MM; Human Genetics Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Cazorla-Jiménez A; Department of Pathology, Fundación Jiménez Díaz-IDC Salud, Madrid, Spain.
  • Muñoz-Repeto I; Human Genetics Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Borrego S; Department of Genetics, Reproduction, and Fetal Medicine, IBIS, University Hospital Virgen del Rocio, CSIC, University of Seville, Seville, Spain.
  • García-Donas J; Biomedical Network Research Centre on Rare Diseases (CIBERER), Madrid, Spain.
  • Hernando S; Medical Oncology Service, Oncologic Center Clara Campal, Madrid, Spain.
  • Robles-Díaz L; Department of Oncology, Fundación Hospital Alcorcón, Alcorcon, Spain.
  • García-Bueno JM; Familial Cancer Unit and Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain.
  • Ramón Y Cajal T; Department of Oncology, Hospital General de Albacete, Albacete, Spain.
  • Hernández-Agudo E; Medical Oncology Service, Hospital Sant Pau, Barcelona, Spain.
  • Heredia Soto V; Breast Cancer Clinical Research Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Márquez-Rodas I; Pathology and Translational Oncology Research Laboratories, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Echarri MJ; Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain.
  • Lacambra-Calvet C; Medical Oncology Service, Hospital Severo Ochoa, Madrid, Spain.
  • Sáez R; Department of Internal Medicine, Hospital Severo Ochoa, Madrid, Spain.
  • Cusidó M; Laboratory of Genetics, Hospital Donostia, San Sebastian, Spain.
  • Redondo A; Department of Obstetrics and Gynecology, Hospital Universitario Quirón-Dexeus, Barcelona, Spain.
  • Paz-Ares L; Department of Medical Oncology, Hospital La Paz IdiPAZ, Madrid, Spain.
  • Hardisson D; Medical Oncology Service, Hospital 12 de Octubre, Madrid, Spain.
  • Mendiola M; Pathology Research Laboratory, Department of Pathology, Hospital La Paz IdiPAZ, and Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain.
  • Palacios J; Pathology and Translational Oncology Research Laboratories, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Benítez J; Department of Pathology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • García MJ; Human Genetics Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
J Gynecol Oncol ; 27(1): e7, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26463438

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Fatores de Transcrição / Cistadenocarcinoma Seroso / Neoplasias Epiteliais e Glandulares Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Fatores de Transcrição / Cistadenocarcinoma Seroso / Neoplasias Epiteliais e Glandulares Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article